Annals of Surgical Oncology

, Volume 3, Issue 6, pp 550–557 | Cite as

Assessing prognosis for high-grade soft-tissue sarcomas: Search for a marker

  • Xiao Qing Li
  • Selene G. Parkekh
  • Andrew E. Rosenberg
  • Henry J. Mankin
Original Articles

Abstract

Background: Although improved staging technology, limb-sparing surgery, and adjunctive radiation and chemotherapy have improved the outlook for patients with malignant soft-tissue tumors of the trunk and extremities, it is evident that we cannot predict which patients will develop distant metastases. Although local control is now frequently achieved, most series of high-grade soft-tissue sarcomas carry a mortality rate of >50%.

Methods: In a retrospective study of 93 patients with high-grade sarcomas treated between 1986 and 1992 for whom complete studies including size and volume measurements and DNA ploidy determinations as assessed by flow cytometry were available, a search for a marker for increased risk of metastasis or death was performed.

Results: Grade of the lesion, sex, diagnosis, anatomical site, ploidic data (including mean DNA index and presence of an aneuploid peak), and treatment factors (including type of surgery, local recurrence, or radiation protocol) did not correlate with outcome. Age (younger patients did better), size (greatest diameter) and volume, and positive margins at surgery correlated with total survival.

Conclusions: The results of the study, although negative, point out that using anatomical site, diagnosis, or ploidic analysis offers little toward anticipating outcome, whereas the size of the tumor is important.

Key Words

Soft tissue Sarcoma Prognosis Flow cytometry 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    American Joint Committee on Cancer. Soft tissues. In: Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, eds.Manual for staging of cancer. 4th ed. Philadelphia: JB Lippincott, 1992:131–6.Google Scholar
  2. 2.
    Eilber RR, Huth JF, Mirra J, Rosen G. Progress in the recognition and treatment of soft tissue sarcomas.Cancer 1990;65:660–6.PubMedGoogle Scholar
  3. 3.
    Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma.Clin Orthop 1980;153:106–20.PubMedGoogle Scholar
  4. 4.
    Greenfield GB, Arrington JA, Kudryk BT. MRI of soft tissue tumors.Skel Radiol 1993;22:77–84.CrossRefGoogle Scholar
  5. 5.
    Hoekstra HJ, Boeve WJ, Kamman RL, Mooyaart EL. Clinical applicability of human in-vivo localized phosphorus-31 magnetic resonance spectroscopy of bone and soft tissue tumors.Ann Surg Oncol 1994;1:504–11.PubMedGoogle Scholar
  6. 6.
    Hogeboom WR, Hoekstra HJ, Mooyaart EL, et al. MRI and CT in the preoperative evaluation of soft-tissue tumors.Arch Orthop Trauma Surg 1991;110:162–4.PubMedGoogle Scholar
  7. 7.
    Kransdorf MJ. Magnetic resonance imaging of musculoskeletal tumors.Orthopedics 1994;17:1003–16.PubMedGoogle Scholar
  8. 8.
    Pazdur R, Baker LH. Staging and sarcoma subtypes: effect on response and survival. In: Raaf JH, ed.Soft tissue sarcomas: diagnosis and treatment. St. Louis: CV Mosby, 1993:69–78.Google Scholar
  9. 9.
    Peabody T, Simon MA. Principles of staging of soft tissue sarcomas.Clin Orthop 1993;289:19–31.PubMedGoogle Scholar
  10. 10.
    Rooser B, Atewell R, Berg NO, Rydholm A. Prognostication in soft tissue sarcoma: a model with four risk factors.Cancer 1988;61:817–23.PubMedGoogle Scholar
  11. 11.
    Rosenthal HG, Terek RM, Lane JM. Management of extremity soft tissue sarcomas.Clin Orthop 1993;289:66–72.PubMedGoogle Scholar
  12. 12.
    Rubin SJ, Feldman F, Haber MM, et al. Magnetic resonance grid analysis of soft tissue lesions.Invest Radiol 1991;26:474–8.PubMedGoogle Scholar
  13. 13.
    O'Connor MI, Pritchard DJ, Gunderson LL. Integration of limb-sparing surgery, brachytherapy and external beam irradiation in the treatment of soft-tissue sarcomas.Clin Orthop 1993;289:73–80.PubMedGoogle Scholar
  14. 14.
    Sadowski C, Suit HD, Rosenberg A, Mankin H, Efird J. Preoperative radiation, surgical margins and local control of extremity sarcomas of soft tissues.J Surg Oncol 1993;52:223–30.Google Scholar
  15. 15.
    Spiro IJ, Rosenberg AE, Springfield D, Suit H. Combined surgery and radiation therapy for limb preservation in soft tissue sarcoma of the extremity: the Massachusetts General Hospital experience.Cancer Invest 1995;13:86–95.PubMedGoogle Scholar
  16. 16.
    Suit JD, Mankin HJ, Wood WCF, et al. Treatment of the patient with stage M0 soft tissue sarcoma.J Clin Oncol 1988;6:854–62.PubMedGoogle Scholar
  17. 17.
    Suit HD, Mankin HJ, Wood WC, Proppe KH. Pre-and post-operative radiation therapy. In: Raaf JH, ed.Soft tissue sarcomas: diagnosis and treatment. St. Louis: CV Mosby, 1993:403–10.Google Scholar
  18. 18.
    Elias AD. Chemotherapy of soft tissue sarcomas.Clin Orthop 1993;289:94–105.PubMedGoogle Scholar
  19. 19.
    Mertens WC, Bramwell VHC. Adjuvant chemotherapy in the treatment of soft-tissue sarcoma.Clin Orthop 1993;289:81–93.PubMedGoogle Scholar
  20. 20.
    Iwamoto Y, Oda Y, Tsumura H, Doi T, Sugioka Y. Three dimensional MRI reconstructions of musculoskeletal tumors. A preliminary evaluation of 2 cases.Acta Orthop Scand 1995;66:80–3.PubMedGoogle Scholar
  21. 21.
    Pritchard DJ, Reiman HM, Turcotte RE, Ilstrup DM. Malignant fibrous histiocytoma of the soft tissues of the trunk and extremities.Clin Orthop 1993;289:58–65.PubMedGoogle Scholar
  22. 22.
    Angervall L, Kindblom L-G. Principles for pathologic-anatomic diagnosis and classification of soft tissue sarcomas.Clin Orthop 1993;289:9–18.PubMedGoogle Scholar
  23. 23.
    Enzinger FM, Weiss SW, eds.Soft tissue tumors. St. Louis: CV Mosby, 1983.Google Scholar
  24. 24.
    Hajdu SI, ed.Pathology of soft tissue tumors. Philadelphia: Lea and Febiger, 1983.Google Scholar
  25. 25.
    Kransdorf MJ. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex and location.AJR 1995;164:129–34.PubMedGoogle Scholar
  26. 26.
    Makley JT. Malignant fibrous lesions of soft tissue. In: Evarts CM, ed.Surgery of the musculoskeletal system. Edinburgh, Scotland: Churchill-Livingstone, 1990:4965–78.Google Scholar
  27. 27.
    Markhede G, Angervall L, Stener B. A multivariate analysis of the prognosis after surgical treatment of malignant soft tissue tumors.Cancer 1982;49:1721–33.PubMedGoogle Scholar
  28. 28.
    Agarwal V, Greenebaum E, Wersto R, Koss LG. DNA ploidy of spindle cell soft tissue tumors and its relationship to histology and clinical outcome.Arch Pathol Lab Med 1991;115:558–62.PubMedGoogle Scholar
  29. 29.
    Eto H, Toriyama K, Tsuda N, Tagawa Y, Itakura H. Flow cytometric DNA analysis of vascular soft tissue tumors, including African endemic-type Kaposi's sarcoma.Hum Pathol 1992;23:1055–60.CrossRefPubMedGoogle Scholar
  30. 30.
    Kreicbergs A, Tibukait B, Willems J, Bauer HC. DNA flow analysis of soft tissue tumors.Cancer 1987;59:128–33.PubMedGoogle Scholar
  31. 31.
    Kreicbergs A. DNA cytometry of musculoskeletal tumors. A review.Acta Orthop Scand 1990;61:282–97.PubMedGoogle Scholar
  32. 32.
    Matsuno T, Gebhardt MC, Schiller AL, et al. The use of flow cytometry as a diagnostic aid in the management of soft-tissue tumors.J Bone Joint Surg 1988;70:751–9.PubMedGoogle Scholar
  33. 33.
    Mellin W, Niezabitowski A, Brockmann M, et al. DNA ploidy in soft tissue tumors: an evaluation of the prognostic implications in the different tumor types.Curr Top Pathol 1995;89:95–121.PubMedGoogle Scholar
  34. 34.
    Remmelink M, Salmon I, Petein M, et al. Determination of DNA ploidy, nuclear size and proliferative activity by means of the computer-assisted image analysis of Feulgen-stained nuclei in 68 soft tissue tumors of adults.Hum Pathol 1994;25:694–701.CrossRefPubMedGoogle Scholar
  35. 35.
    Van den Berg E, Van Oven MW, deJong B, et al. Comparison of cytogenetic abnormalities and deoxyribonucleic acid ploidy of benign, borderline malignant, and different grades of malignant soft tissue tumors.Lab Invest 1994;70:307–13.PubMedGoogle Scholar
  36. 36.
    Frable WJ. Pathologic classification of soft tissue sarcomas.Semin Surg Oncol 1994;10:332–9.PubMedGoogle Scholar
  37. 37.
    Sreekantaiah C, Ladanyi M, Rodriguez E, Chaganti RS. Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification and molecular mechanisms.Am J Pathol 1994;144:1121–34.PubMedGoogle Scholar
  38. 38.
    Weiner TM, Liu ET, Craven RJ, Cance WG. Expression of growth factor receptors, the focal adhesion kinase and other tyrosine kinases in human soft tissue tumors.Ann Surg Oncol 1994;1:18–27.CrossRefPubMedGoogle Scholar
  39. 39.
    Mankin HJ, Connor JF, Schiller AL, et al. Grading of bone tumors by analysis of nuclear DNA content using flow cytometry.J Bone Joint Surg [Am] 1985;67:404–13.Google Scholar
  40. 40.
    Mankin HJ, Gebhardt MC, Springfield DS, et al. Flow cytometric studies of human osteosarcoma.Clin Orthop 1990;270:169–80.Google Scholar
  41. 41.
    Risberg B, Stal O, Bjelkenkrantz K, et al. Use of formalin fixed, paraffin embedded tumours for estimation of cellular DNA content and S-phase fraction by static cytofluorometry.Acta Radiol Oncol 1985;24:537–44.PubMedGoogle Scholar
  42. 42.
    Stal O, Klintenbeg C, Franzen G, et al. A comparison of static cytofluorometry and flow cytometry for the estimation of ploidy and DNA replication in human breast cancer.Breast Cancer Res Treat 1986;7:15–22.PubMedGoogle Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 1996

Authors and Affiliations

  • Xiao Qing Li
    • 1
  • Selene G. Parkekh
    • 1
  • Andrew E. Rosenberg
    • 1
  • Henry J. Mankin
    • 1
  1. 1.From the Orthopaedic Oncology Unit, Orthopaedic Service, and the Connective Tissue Oncology Center, Massachusetts General HospitalHarvard Medical SchoolBostonUSA

Personalised recommendations